老年性糖尿病视网膜病变138例的用药方案分析

目的探讨胰岛素联用复方血栓通胶囊、羟苯磺酸钙胶囊治疗老年性糖尿病视网病变（DR）的临床疗效。方法从1409例老年性糖尿病患者中选出伴有视网膜病变的1076例,将随机抽取的138例患者分为3组,即胰岛素控制血糖对照组（A组）、胰岛素联用复方血栓通胶囊治疗组（B组）及胰岛素联用羟苯磺酸钙胶囊治疗组（C组）。结果 A组、B组、C组的总有效率分别为78.26%,86.96%,89.13%,组间疗效存在显著差异（P〈0.05）。结论胰岛素联用复方血栓通胶囊或羟苯磺酸钙胶囊治疗老年性糖尿病视网病变的疗效优于单用胰岛素,辅以对症食疗和药膳指导,临床疗效更好。

Analysis on Medication Schemes of Senile Diabetic Retinopathy in 138 Cases

Objective To investigate the clinical efficacy of insulin combined with Compound Xueshuantong Capsule and Calcium Dobesilate Capsule in the treatment of senile diabetic retinopathy （DR）.Methods 1 076 cases of diabetic retinopathy were selected from 1 409 cases of senile diabetes mellitus.138 cases were randomly selected from them and divided into three groups,insulin control（A）,insulin combined with Compound Xueshuantong Capsule（B） and insulin combined with Calcium Dobesilate Capsule（C）.Results The total effective rate was 78.26%in group A,86.96%in group B and 89.13%in group C respectively with significant difference between the groups（P 0.05）. Conclusion Insulin combined with Compound Xueshuantong Capsule and Calcium Dobesilate Capsule is superior to insulin alone in the treatment of senile diabetic retinopathy,which assisted by symptomatic medicated food and guidance can play better clinical efficacy.